John Gordon

Summary

Co-founder and CSO of Celentyx Ltd.
Professor Emeritus of Cellular Immunology and Head of College of Medical and Dental Sciences Graduate School, University of Birmingham.
Raine Visiting Professor, University of Western Australia.

John Gordon is an internationally recognised authority on immune cell biology and immune cell-mediated diseases. For the past decade or so, John has been pioneering the field of Neuro-Immuno-Pharmacology. He is one of the world’s most highly cited researchers (www.ISIHighlyCited.com) and has a proven track record in the successful application of research within the field of translational medicine.

Cell Biology Hematology Immunology Pharmacology Translational Medicine

Past or current institution affiliations

University of Birmingham

Work details

CSO, Director, co-Founder

Celentyx Ltd

http://celentyx.com/people.html

Celentyx offers bespoke Human Immuno-Profiling opportunities to partners in strategic alliance with leading international expertise in immune cell subtypes and associated pathologies within the MRC Centre for Immune Regulation at Birmingham, U.K. to mine Mechanisms of Action and disclose novel applications for new and reprofiled drugs/compounds. Predictive immuno-toxicology (unwanted reactions) can also be profiled. Specialities (compound versus human cell subsets) include assay, enumeration, and function of: Tregs; TH17; TH1/TH2; NK & NKT; Bregs; naive versus memory B cells; B1 cells; monocytes/macrophages; DCs; haematological malignancies. More recently, Celentyx has developed a suite of sophisticated platforms for evaluating novel and established biologics in the burgeoning ImmunoOncology space.

Professor Emeritus of Cellular Immunology

University of Birmingham

School of Immunity & Infection

As well as being an international force in his chosen research field of Human B-cell Biology & Pathophysiology, John has been a senior figure in the administration of the College of Medical & Dental Sciences at Birmingham holding a number of posts including that of Head of Graduate School and Associate Director of Research & Knowledge Transfer. He retired and earned Professor Emeritus status in July 2013.

Websites

PeerJ Contributions

Edited 1

Academic Editor on

February 12, 2013

Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells

13 citations

1,078 downloads

4,253 views

George W. Small, Howard L. McLeod, Kristy L. Richards

https://doi.org/10.7717/peerj.31 PubMed 23638367